UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study

Journal of clinical oncology, 2014-01, Vol.32 (1), p.34-43

2014

Volltextzugriff (PDF)

Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3753-3760

2011

Volltextzugriff (PDF)

Impact of Short-Course Preoperative Radiotherapy for Rectal Cancer on Patients' Quality of Life: Data From the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 Randomized Clinical Trial

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4233-4239

2010

Volltextzugriff (PDF)

Identifying Social Distress: A Cross-Sectional Survey of Social Outcomes 12 to 36 Months After Colorectal Cancer Diagnosis

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3423-3430

2015

Volltextzugriff (PDF)

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

Journal of clinical oncology, 2020-08, Vol.38 (22), p.2510-2518

2020

Volltextzugriff (PDF)

Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis

Journal of clinical oncology, 2015-02, Vol.33 (6), p.616-624

2015

Volltextzugriff (PDF)

STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3502-3502

2022

Volltextzugriff (PDF)

Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?

Journal of clinical oncology, 2010-10, Vol.28 (29), p.e579-e580

2010

Volltextzugriff (PDF)

SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.TPS536-TPS536

2018

Volltextzugriff (PDF)

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4101-4101

2020

Volltextzugriff (PDF)

Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.373-373

2020

Volltextzugriff (PDF)

Compliance to chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) according to radiotherapy (RT) dose, overall treatment time (OTT) and chemotherapy (CT) and their impact on long-term outcome: Results of ACT II

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3518-3518

2015

Volltextzugriff (PDF)

Salvage surgery with abdominoperineal excision of the rectum (APER) following loco-regional failure after chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA) and the impact on long-term outcomes: Results of ACT II

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3523-3523

2016

Volltextzugriff (PDF)

Patient and tumor characteristics impacting on lymph node metastases rate (LNMR) in squamous cell carcinoma of the anal canal and margin (SCCA) using data from the NCRI randomized phase III ACT II trial: Implications for radiotherapy target volume

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4032-4032

2014

Volltextzugriff (PDF)

A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3609-3609

2015

Volltextzugriff (PDF)

NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.3-3

2016

Volltextzugriff (PDF)

Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4664-4665

2006

Volltextzugriff (PDF)

Pretreatment and postresection epidermal growth factor receptor (EGFR) pathway mutations in a prospective phase II trial (EXCITE) of preoperative cetuximab-containing chemoradiation (CRT) in locally advanced rectal cancer (LARC)

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.458-458

2014

Volltextzugriff (PDF)

Tumor-related and treatment-related colostomy-free survival (CFS) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA): Results of ACT II

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.3532-3532

2013

Volltextzugriff (PDF)

The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4029-4029

2012

Volltextzugriff (PDF)

Optimum time to assess complete clinical response (CR) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance CisP/5FU in squamous cell carcinoma of the anus: Results of ACT II

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4004-4004

2012

Volltextzugriff (PDF)

NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS4144-TPS4144

2014

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(8)
Life Sciences & Biomedicine
(8)
Oncology
(8)
Science & Technology
(8)
Aged
(6)
Female
(6)
Male
(6)
Middle Aged
(6)
Rectal Neoplasms - Radiotherapy
(4)
Aged, 80 And Over
(3)
Biological And Medical Sciences
(3)
Disease-Free Survival
(3)
Medical Sciences
(3)
Radiotherapy, Adjuvant
(3)
Rectal Neoplasms - Surgery
(3)
Surveys And Questionnaires
(3)
Treatment Outcome
(3)
Tumors
(3)
Adult
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study

Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience

Impact of Short-Course Preoperative Radiotherapy for Rectal Cancer on Patients' Quality of Life: Data From the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 Randomized Clinical Trial

Identifying Social Distress: A Cross-Sectional Survey of Social Outcomes 12 to 36 Months After Colorectal Cancer Diagnosis

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis

STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?

Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?

SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC)

Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial

Patient and tumor characteristics impacting on lymph node metastases rate (LNMR) in squamous cell carcinoma of the anal canal and margin (SCCA) using data from the NCRI randomized phase III ACT II trial: Implications for radiotherapy target volume

A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171)

NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma

Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study

InterAACT: An international multicenter open label randomized phase II advanced anal cancer trial comparing cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus carboplatin (CBDCA) plus weekly paclitaxel (PTX) in patients with inoperable locally recurrent (ILR) or metastatic disease

Pretreatment and postresection epidermal growth factor receptor (EGFR) pathway mutations in a prospective phase II trial (EXCITE) of preoperative cetuximab-containing chemoradiation (CRT) in locally advanced rectal cancer (LARC)

Tumor-related and treatment-related colostomy-free survival (CFS) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA): Results of ACT II

The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial

Optimum time to assess complete clinical response (CR) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance CisP/5FU in squamous cell carcinoma of the anus: Results of ACT II

NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer

Aktive Filter

Suchergebnisse filtern